TAK: Takeda Pharmaceutical Co Ltd insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
380 institutions reported holding $1.65B of Takeda Pharmaceutical Co Ltd on Form 13F (363 the quarter before). 61 opened a new position and 40 sold out. Shares held by institutions: +6%.
| Largest holders | Shares | Value |
|---|---|---|
| Capital Research Global Investors | 19,297,680 | $309.34M |
| FMR LLC | 9,599,302 | $153.88M |
| MORGAN STANLEY | 6,994,924 | $112.13M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6,050,771 | $96.99M |
| GOLDMAN SACHS GROUP INC | 5,125,032 | $82.15M |
| BRANDES INVESTMENT PARTNERS, LP | 4,539,347 | $72.77M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3,732,924 | $59.84M |
| BlackRock, Inc. | 3,688,166 | $59.12M |
| RENAISSANCE TECHNOLOGIES LLC | 2,568,000 | $41.17M |
| Qube Research & Technologies Ltd | 2,207,432 | $35.39M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.